Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.

Filter

Date Title Topic
14 Jul 2016 World GI 2016 Press Release: The Debate on the Phase 3 Trial of MABp1 Presented at the 18th ESMO World Congress on Gastrointestinal Cancer Gastrointestinal cancers - Cancer Immunology and Immunotherapy
13 Jul 2016 Statistical Perspective on Adaptive Strategy for Matching Targeted Therapies with the Patients Most Likely to Benefit Breast cancer - Anticancer agents & Biologic therapy
12 Jul 2016 Biomarker Tests for Molecularly Targeted Therapies Personalised medicine - Bioethics, legal and economic issues
11 Jul 2016 FDA Advances Precision Medicine Initiative by Issuing Two Draft Guidances on NGS-Based Tests Personalised medicine - Bioethics, legal and economic issues
07 Jul 2016 Press Release: Results of First Study Assessing Clinical Impact of ESMO-MCBS
07 Jul 2016 NICE Issues Quality Standard on Suspected Cancer Epidemiology/Etiology/Cancer Prevention - Imaging
06 Jul 2016 Press Release: ESMO Releases New Consensus Guidelines on the Management of Metastatic Colorectal Cancer Gastrointestinal cancers
06 Jul 2016 EMA Recommends to Refuse a Change to the Marketing Authorisation for Ofatumumab Haematologic malignancies - Anticancer agents & Biologic therapy
02 Jul 2016 World GI 2016 Press Release: Anti-Interleukin-1 Alpha Antibody MABp1 Improves Outcomes Significantly Over Placebo Gastrointestinal cancers - Cancer Immunology and Immunotherapy
30 Jun 2016 World GI 2016 Press Release: Regorafenib Shows Significant Survival Gains in Refractory Liver Cancer Gastrointestinal cancers - Anticancer agents & Biologic therapy
30 Jun 2016 World GI 2016 Press Release: Chemoradiotherapy After Surgery for Gastric Cancer Shows Similar Outcomes to Post-Operative Chemotherapy Gastrointestinal cancers - Anticancer agents & Biologic therapy
30 Jun 2016 NICE Issues Technology Appraisal Guidance for Ceritinib Personalised medicine - Lung and other thoracic tumours - Anticancer agents & Biologic therapy
29 Jun 2016 World GI 2016 Press Release: Anti-PD-L1 Immunotherapy Shows Response in Microsatellite-Stable Metastatic Colorectal Cancer in Combination with MEK Inhibition Gastrointestinal cancers - Cancer Immunology and Immunotherapy
28 Jun 2016 EMA Recommends To Extend Indications for Pembrolizumab Lung and other thoracic tumours - Cancer Immunology and Immunotherapy
27 Jun 2016 EMA Reviews Gadolinium Contrast Agents Used in MRI Scans Imaging